During the last session, DarioHealth Corp (NASDAQ:DRIO)’s traded shares were 0.4 million, with the beta value of the company hitting 1.44. At the end of the trading day, the stock’s price was $0.75, reflecting an intraday gain of 7.14% or $0.05. The 52-week high for the DRIO share is $1.93, that puts it down -157.33 from that peak though still a striking 33.33% gain since the share price plummeted to a 52-week low of $0.50. The company’s market capitalization is $31.18M, and the average intraday trading volume over the past 10 days was 0.42 million shares, and the average trade volume was 414.50K shares over the past three months.
DarioHealth Corp (DRIO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.67. DRIO has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.05.
DarioHealth Corp (NASDAQ:DRIO) trade information
DarioHealth Corp (DRIO) registered a 7.14% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 7.14% in intraday trading to $0.75, hitting a weekly high. The stock’s 5-day price performance is 34.89%, and it has moved by 4.17% in 30 days. Based on these gigs, the overall price performance for the year is -35.90%. The short interest in DarioHealth Corp (NASDAQ:DRIO) is 2.7 million shares and it means that shorts have 10.0 day(s) to cover.
The consensus price target of analysts on Wall Street is $10.75, which implies an increase of 93.02% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $7.5 and $14 respectively. As a result, DRIO is trading at a discount of -1766.67% off the target high and -900.0% off the low.
DarioHealth Corp (DRIO) estimates and forecasts
In the rating firms’ projections, revenue will increase 20.01% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 7.47M as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 7.76M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 5.76M and 6.25M respectively. In this case, analysts expect current quarter sales to grow by 29.81% and then jump by 24.09% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 41.84%. While earnings are projected to return 57.38% in 2025, the next five years will return 56.56% per annum.
DRIO Dividends
DarioHealth Corp is due to release its next quarterly earnings on 2025-Mar-09. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
DarioHealth Corp (NASDAQ:DRIO)’s Major holders
DarioHealth Corp insiders own 21.28% of total outstanding shares while institutional holders control 20.20%, with the float percentage being 25.66%. NANTAHALA CAPITAL MANAGEMENT, LLC is the largest shareholder of the company, while 45.0 institutions own stock in it. As of 2024-06-30, the company held over 2.39 million shares (or 6.9429% of all shares), a total value of $2.85 million in shares.
The next largest institutional holding, with 1.38 million shares, is of APPIAN WAY ASSET MANAGEMENT LP’s that is approximately 3.9947% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.64 million.
Also, the Mutual Funds coming in first place with the largest holdings of DarioHealth Corp (DRIO) shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund owns about 355.61 shares. This amounts to just over 0.86 percent of the company’s overall shares, with a $0.27 million market value. The same data shows that the other fund manager holds slightly less at 146.08, or about 0.35% of the stock, which is worth about $0.11 million.
